Skip to content
akaturk Academic measurement

Article detail · 2024

Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study

Journal

Journal of Oncology Pharmacy Practice

ISSN 1078-1552

YÖKSİS OpenAlex SJR Q3 JCR Q4 Citations 0 Percentile 19.7% FWCI 0.0
Year
2024
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Journal of Oncology Pharmacy Practice
  • Catalog match (ISSN) Journal of Oncology Pharmacy Practice
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Background and AimChronic myeloid leukemia (CML) incidence has recently increased in younger individuals. With time, given the nature of the disease and available therapies, as well as the existing paucity and inconsistency of advice, worries about fertility have surfaced. With all these clear unknowns, we designed this study to raise awareness among both physicians and CML patients about whether male and female patients of childbearing age were using contraception at the time of diagnosis, and if so, which methods they were using. In this context, this study aimed to evaluate the contraception methods in patients with CML.Materials and MethodsEighteen centres from Turkey participated in the study. Male and female patients of childbearing age diagnosed with chronic and accelerated phase CML between the years 2000 and 2024 were evaluated retrospectively.ResultsOf the two hundred and thirty-two patients included, one hundred and twenty-five (53.9%) of these patients were female and 107 (46.1%) were male. At diagnosis, all female patients were in the childbearing age, and male patients were sexually active. The median age at diagnosis of the patients was 38 (range, 18-77) years. Eighty-six (68.8%) female patients were using any contraception method, while this was 53.2% (n = 57) among male patients.ConclusionIn conclusion, since CML patients are diagnosed at an earlier age and the desire of these patients to have children, adequate information and evaluation should be provided regarding fertility and contraception issues, especially in female patients, from the moment of diagnosis.

Topics

  • Chronic Myeloid Leukemia Treatments
  • Reproductive System and Pregnancy
  • Kruppel-like factors research

Primary topic Chronic Myeloid Leukemia Treatments

Authors

  1. Rafiye Çiftçiler
  2. CEM SELİM
  3. Melda Cömert
  4. HAYDAR ZENGİN
  5. Yıdız İpek
  6. Vildan Gürsoy
  7. ESRA YILDIZHAN
  8. Abdülkerim Yıldız
  9. SAMET YAMAN
  10. TAYFUN ELİBOL
  11. SERKAN GÜVEN
  12. EREN ARSLAN DAVULCU
  13. DENİZ ÖZMEN İBİŞ
  14. ATAKAN TEKİNALP NECMETTİN ERBAKAN ÜNİVERSİTESİ
  15. Zehra Narlı Özdemir
  16. MEHMET BAYSAL
  17. SİNAN MERSİN
  18. ZEYNEP GÜVEN ÖZDEMİR
  19. İbrahim Ethem Pınar
  20. SERHAT ÇELİK
  21. Ahmet Emre Eşkazan